Phase II Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined with Sintilimab and S-1 in the Conversion Treatment of HER2-overexpression Unresectable Gastric Cancer.
Journal of Clinical Oncology（2024）
关键词
281-270-434-6184,281-318-430,281-270-2686-7624,283-424-6846-174,283-424-6846-5514,613-135-244-3829-325,2444,4288,2444,4288
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要